A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects with Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects

Sponsor ID

20010198

Clinicaltrials.gov ID

NCT00117247

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

The purpose of this study is to evaluate the single dose pharmacokinetics (PK) of subcutaneous (SC) darbepoetin alfa in subjects with congestive heart failure (CHF) and anemia.

Additional Study Details

Phase

Phase 1/Phase 2

Product

darbepoetin alfa

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Protocol Summary

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Locations

No locations found.